1.46
|
1.53e-86
|
GO:0044237
|
cellular metabolic process
|
1.59
|
1.33e-83
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.50
|
8.68e-74
|
GO:0043170
|
macromolecule metabolic process
|
1.37
|
3.38e-71
|
GO:0008152
|
metabolic process
|
1.40
|
1.76e-69
|
GO:0044238
|
primary metabolic process
|
1.72
|
1.03e-67
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.21
|
2.82e-64
|
GO:0009987
|
cellular process
|
1.62
|
7.50e-61
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.61
|
1.63e-60
|
GO:0006807
|
nitrogen compound metabolic process
|
1.78
|
1.95e-60
|
GO:0090304
|
nucleic acid metabolic process
|
1.79
|
1.51e-50
|
GO:0010467
|
gene expression
|
1.80
|
2.69e-48
|
GO:0016070
|
RNA metabolic process
|
1.59
|
1.37e-40
|
GO:0044267
|
cellular protein metabolic process
|
1.56
|
2.96e-40
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.48
|
5.21e-40
|
GO:0071840
|
cellular component organization or biogenesis
|
1.73
|
6.17e-39
|
GO:0009059
|
macromolecule biosynthetic process
|
1.72
|
2.45e-37
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.45
|
4.22e-34
|
GO:0016043
|
cellular component organization
|
1.54
|
1.52e-33
|
GO:0009058
|
biosynthetic process
|
1.52
|
1.79e-33
|
GO:0071842
|
cellular component organization at cellular level
|
1.55
|
1.96e-33
|
GO:0044249
|
cellular biosynthetic process
|
2.27
|
1.31e-32
|
GO:0016071
|
mRNA metabolic process
|
2.15
|
1.34e-32
|
GO:0006396
|
RNA processing
|
1.47
|
2.16e-31
|
GO:0019538
|
protein metabolic process
|
2.37
|
6.39e-29
|
GO:0016032
|
viral reproduction
|
2.57
|
1.14e-27
|
GO:0006412
|
translation
|
1.63
|
2.54e-27
|
GO:0006996
|
organelle organization
|
2.91
|
1.33e-26
|
GO:0000375
|
RNA splicing, via transesterification reactions
|
2.52
|
8.51e-26
|
GO:0008380
|
RNA splicing
|
2.91
|
1.01e-25
|
GO:0000377
|
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile
|
2.91
|
1.01e-25
|
GO:0000398
|
nuclear mRNA splicing, via spliceosome
|
2.05
|
4.09e-24
|
GO:0000278
|
mitotic cell cycle
|
2.27
|
2.53e-23
|
GO:0006397
|
mRNA processing
|
1.80
|
3.16e-21
|
GO:0043933
|
macromolecular complex subunit organization
|
2.73
|
5.31e-21
|
GO:0022613
|
ribonucleoprotein complex biogenesis
|
1.66
|
1.07e-20
|
GO:0044085
|
cellular component biogenesis
|
1.88
|
1.46e-20
|
GO:0022403
|
cell cycle phase
|
1.93
|
2.05e-20
|
GO:0009057
|
macromolecule catabolic process
|
2.04
|
5.32e-20
|
GO:0034621
|
cellular macromolecular complex subunit organization
|
2.00
|
9.95e-20
|
GO:0044265
|
cellular macromolecule catabolic process
|
2.62
|
2.08e-19
|
GO:0071843
|
cellular component biogenesis at cellular level
|
1.61
|
3.87e-19
|
GO:0051641
|
cellular localization
|
1.68
|
9.89e-19
|
GO:0007049
|
cell cycle
|
1.78
|
1.34e-18
|
GO:0046907
|
intracellular transport
|
1.63
|
8.71e-18
|
GO:0051649
|
establishment of localization in cell
|
1.75
|
1.47e-17
|
GO:0022402
|
cell cycle process
|
1.61
|
4.49e-17
|
GO:0044248
|
cellular catabolic process
|
2.48
|
9.56e-17
|
GO:0000075
|
cell cycle checkpoint
|
1.39
|
9.74e-17
|
GO:0048522
|
positive regulation of cellular process
|
2.58
|
1.15e-16
|
GO:0022411
|
cellular component disassembly
|
2.58
|
1.15e-16
|
GO:0071845
|
cellular component disassembly at cellular level
|
1.84
|
1.70e-16
|
GO:0051726
|
regulation of cell cycle
|
2.14
|
1.81e-16
|
GO:0010564
|
regulation of cell cycle process
|
2.43
|
2.07e-16
|
GO:0071156
|
regulation of cell cycle arrest
|
1.91
|
4.40e-16
|
GO:0006974
|
response to DNA damage stimulus
|
2.68
|
7.22e-16
|
GO:0022415
|
viral reproductive process
|
1.36
|
8.09e-16
|
GO:0048518
|
positive regulation of biological process
|
1.84
|
9.61e-16
|
GO:0071822
|
protein complex subunit organization
|
1.70
|
9.80e-16
|
GO:0033554
|
cellular response to stress
|
1.31
|
1.24e-15
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.51
|
3.87e-15
|
GO:0009056
|
catabolic process
|
3.29
|
4.50e-15
|
GO:0019080
|
viral genome expression
|
3.29
|
4.50e-15
|
GO:0019083
|
viral transcription
|
2.77
|
6.32e-15
|
GO:0019058
|
viral infectious cycle
|
3.24
|
6.53e-15
|
GO:0006415
|
translational termination
|
2.95
|
7.78e-15
|
GO:0051320
|
S phase
|
1.62
|
9.46e-15
|
GO:0032774
|
RNA biosynthetic process
|
2.16
|
1.03e-14
|
GO:0051329
|
interphase of mitotic cell cycle
|
2.96
|
1.23e-14
|
GO:0000084
|
S phase of mitotic cell cycle
|
2.71
|
1.24e-14
|
GO:0000082
|
G1/S transition of mitotic cell cycle
|
2.14
|
1.76e-14
|
GO:0051325
|
interphase
|
3.05
|
2.05e-14
|
GO:0006414
|
translational elongation
|
2.94
|
3.70e-14
|
GO:0032984
|
macromolecular complex disassembly
|
2.94
|
3.70e-14
|
GO:0034623
|
cellular macromolecular complex disassembly
|
2.81
|
3.89e-14
|
GO:0042254
|
ribosome biogenesis
|
2.03
|
3.97e-14
|
GO:0030163
|
protein catabolic process
|
1.51
|
5.23e-14
|
GO:0033036
|
macromolecule localization
|
1.59
|
7.29e-14
|
GO:0042981
|
regulation of apoptosis
|
3.04
|
9.95e-14
|
GO:0043241
|
protein complex disassembly
|
3.04
|
9.95e-14
|
GO:0043624
|
cellular protein complex disassembly
|
2.07
|
1.10e-13
|
GO:0051603
|
proteolysis involved in cellular protein catabolic process
|
2.26
|
1.16e-13
|
GO:0032269
|
negative regulation of cellular protein metabolic process
|
1.79
|
1.26e-13
|
GO:0006259
|
DNA metabolic process
|
2.08
|
1.46e-13
|
GO:0043632
|
modification-dependent macromolecule catabolic process
|
1.16
|
1.91e-13
|
GO:0065007
|
biological regulation
|
1.56
|
2.20e-13
|
GO:0051246
|
regulation of protein metabolic process
|
3.24
|
2.46e-13
|
GO:0000216
|
M/G1 transition of mitotic cell cycle
|
1.57
|
2.59e-13
|
GO:0043067
|
regulation of programmed cell death
|
2.21
|
3.90e-13
|
GO:0051248
|
negative regulation of protein metabolic process
|
1.56
|
3.91e-13
|
GO:0010941
|
regulation of cell death
|
2.03
|
6.52e-13
|
GO:0044257
|
cellular protein catabolic process
|
2.05
|
6.52e-13
|
GO:0019941
|
modification-dependent protein catabolic process
|
1.53
|
8.51e-13
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
2.06
|
8.71e-13
|
GO:0006511
|
ubiquitin-dependent protein catabolic process
|
1.26
|
9.42e-13
|
GO:0019222
|
regulation of metabolic process
|
1.52
|
9.47e-13
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.69
|
1.24e-12
|
GO:0006915
|
apoptosis
|
1.62
|
1.32e-12
|
GO:0016265
|
death
|
1.56
|
1.42e-12
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.60
|
1.46e-12
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.16
|
1.58e-12
|
GO:0050789
|
regulation of biological process
|
1.50
|
1.69e-12
|
GO:0009893
|
positive regulation of metabolic process
|
1.68
|
1.84e-12
|
GO:0012501
|
programmed cell death
|
1.27
|
2.26e-12
|
GO:0031323
|
regulation of cellular metabolic process
|
1.61
|
2.62e-12
|
GO:0008219
|
cell death
|
1.97
|
3.33e-12
|
GO:0044419
|
interspecies interaction between organisms
|
1.55
|
3.63e-12
|
GO:0022607
|
cellular component assembly
|
1.59
|
4.77e-12
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.56
|
5.83e-12
|
GO:0009892
|
negative regulation of metabolic process
|
1.36
|
6.80e-12
|
GO:0048523
|
negative regulation of cellular process
|
3.09
|
7.12e-12
|
GO:0031145
|
anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process
|
1.67
|
7.51e-12
|
GO:0065003
|
macromolecular complex assembly
|
2.44
|
1.62e-11
|
GO:0010498
|
proteasomal protein catabolic process
|
2.44
|
1.62e-11
|
GO:0043161
|
proteasomal ubiquitin-dependent protein catabolic process
|
1.26
|
2.80e-11
|
GO:0080090
|
regulation of primary metabolic process
|
1.33
|
2.96e-11
|
GO:0048519
|
negative regulation of biological process
|
1.16
|
3.02e-11
|
GO:0050794
|
regulation of cellular process
|
2.62
|
1.39e-10
|
GO:0031018
|
endocrine pancreas development
|
2.95
|
1.61e-10
|
GO:0051351
|
positive regulation of ligase activity
|
1.51
|
1.89e-10
|
GO:0008104
|
protein localization
|
3.01
|
2.11e-10
|
GO:0051439
|
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle
|
1.36
|
2.43e-10
|
GO:0043412
|
macromolecule modification
|
1.57
|
2.66e-10
|
GO:0015031
|
protein transport
|
2.80
|
2.69e-10
|
GO:0051340
|
regulation of ligase activity
|
2.54
|
3.60e-10
|
GO:0007093
|
mitotic cell cycle checkpoint
|
2.97
|
4.05e-10
|
GO:0051443
|
positive regulation of ubiquitin-protein ligase activity
|
2.04
|
4.19e-10
|
GO:0007346
|
regulation of mitotic cell cycle
|
1.74
|
4.87e-10
|
GO:0070727
|
cellular macromolecule localization
|
1.31
|
6.09e-10
|
GO:0006950
|
response to stress
|
1.37
|
6.16e-10
|
GO:0006464
|
protein modification process
|
1.55
|
6.41e-10
|
GO:0045184
|
establishment of protein localization
|
2.81
|
6.97e-10
|
GO:0051438
|
regulation of ubiquitin-protein ligase activity
|
3.05
|
8.22e-10
|
GO:0051437
|
positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle
|
2.62
|
9.54e-10
|
GO:0031398
|
positive regulation of protein ubiquitination
|
1.73
|
1.25e-09
|
GO:0034613
|
cellular protein localization
|
1.97
|
1.40e-09
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
3.08
|
2.02e-09
|
GO:0051436
|
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle
|
2.00
|
2.04e-09
|
GO:0034660
|
ncRNA metabolic process
|
3.02
|
2.53e-09
|
GO:0051352
|
negative regulation of ligase activity
|
3.02
|
2.53e-09
|
GO:0051444
|
negative regulation of ubiquitin-protein ligase activity
|
2.86
|
2.59e-09
|
GO:0022618
|
ribonucleoprotein complex assembly
|
2.39
|
2.80e-09
|
GO:0031016
|
pancreas development
|
1.94
|
3.47e-09
|
GO:0048285
|
organelle fission
|
2.29
|
4.12e-09
|
GO:0031400
|
negative regulation of protein modification process
|
2.75
|
5.55e-09
|
GO:0006364
|
rRNA processing
|
1.81
|
6.27e-09
|
GO:0006886
|
intracellular protein transport
|
1.81
|
7.05e-09
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
2.34
|
9.36e-09
|
GO:0031396
|
regulation of protein ubiquitination
|
1.91
|
9.69e-09
|
GO:0031401
|
positive regulation of protein modification process
|
1.79
|
1.07e-08
|
GO:0051247
|
positive regulation of protein metabolic process
|
1.82
|
1.95e-08
|
GO:0034622
|
cellular macromolecular complex assembly
|
1.86
|
1.99e-08
|
GO:0070647
|
protein modification by small protein conjugation or removal
|
2.77
|
2.33e-08
|
GO:2000045
|
regulation of G1/S transition of mitotic cell cycle
|
1.62
|
3.23e-08
|
GO:0051276
|
chromosome organization
|
1.91
|
3.61e-08
|
GO:0000280
|
nuclear division
|
1.91
|
3.61e-08
|
GO:0007067
|
mitosis
|
1.93
|
4.13e-08
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
2.70
|
4.25e-08
|
GO:0071826
|
ribonucleoprotein complex subunit organization
|
1.89
|
4.29e-08
|
GO:0000087
|
M phase of mitotic cell cycle
|
2.98
|
5.84e-08
|
GO:0071158
|
positive regulation of cell cycle arrest
|
1.55
|
5.89e-08
|
GO:0071844
|
cellular component assembly at cellular level
|
2.78
|
6.06e-08
|
GO:0031575
|
mitotic cell cycle G1/S transition checkpoint
|
2.78
|
6.06e-08
|
GO:0071779
|
G1/S transition checkpoint
|
2.67
|
7.14e-08
|
GO:0031397
|
negative regulation of protein ubiquitination
|
2.60
|
7.43e-08
|
GO:0016072
|
rRNA metabolic process
|
2.14
|
1.09e-07
|
GO:0035270
|
endocrine system development
|
1.80
|
1.38e-07
|
GO:0051301
|
cell division
|
2.42
|
1.55e-07
|
GO:0031570
|
DNA integrity checkpoint
|
2.46
|
1.72e-07
|
GO:0042770
|
signal transduction in response to DNA damage
|
1.90
|
1.73e-07
|
GO:0032446
|
protein modification by small protein conjugation
|
3.48
|
2.13e-07
|
GO:0006413
|
translational initiation
|
2.43
|
4.26e-07
|
GO:0000077
|
DNA damage checkpoint
|
1.52
|
4.61e-07
|
GO:0016192
|
vesicle-mediated transport
|
1.78
|
5.22e-07
|
GO:0006281
|
DNA repair
|
1.63
|
9.99e-07
|
GO:0043065
|
positive regulation of apoptosis
|
2.41
|
1.05e-06
|
GO:0090068
|
positive regulation of cell cycle process
|
1.89
|
1.14e-06
|
GO:0016567
|
protein ubiquitination
|
2.87
|
1.53e-06
|
GO:0006977
|
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
2.87
|
1.53e-06
|
GO:0072395
|
signal transduction involved in cell cycle checkpoint
|
2.87
|
1.53e-06
|
GO:0072401
|
signal transduction involved in DNA integrity checkpoint
|
2.87
|
1.53e-06
|
GO:0072404
|
signal transduction involved in G1/S transition checkpoint
|
2.87
|
1.53e-06
|
GO:0072413
|
signal transduction involved in mitotic cell cycle checkpoint
|
2.87
|
1.53e-06
|
GO:0072422
|
signal transduction involved in DNA damage checkpoint
|
2.87
|
1.53e-06
|
GO:0072431
|
signal transduction involved in mitotic cell cycle G1/S transition DNA damage checkpoint
|
2.87
|
1.53e-06
|
GO:0072474
|
signal transduction involved in mitotic cell cycle G1/S checkpoint
|
2.28
|
1.54e-06
|
GO:0006403
|
RNA localization
|
1.61
|
1.65e-06
|
GO:0010942
|
positive regulation of cell death
|
1.62
|
1.66e-06
|
GO:0043068
|
positive regulation of programmed cell death
|
2.08
|
1.70e-06
|
GO:0043687
|
post-translational protein modification
|
3.01
|
1.77e-06
|
GO:0006521
|
regulation of cellular amino acid metabolic process
|
1.25
|
1.93e-06
|
GO:0010468
|
regulation of gene expression
|
1.67
|
2.23e-06
|
GO:0000279
|
M phase
|
2.73
|
3.23e-06
|
GO:0031571
|
mitotic cell cycle G1/S transition DNA damage checkpoint
|
1.45
|
3.34e-06
|
GO:0006351
|
transcription, DNA-dependent
|
2.69
|
3.38e-06
|
GO:0050792
|
regulation of viral reproduction
|
2.52
|
3.44e-06
|
GO:0030330
|
DNA damage response, signal transduction by p53 class mediator
|
2.27
|
3.93e-06
|
GO:0050657
|
nucleic acid transport
|
2.27
|
3.93e-06
|
GO:0050658
|
RNA transport
|
2.27
|
3.93e-06
|
GO:0051236
|
establishment of RNA localization
|
1.97
|
5.24e-06
|
GO:0006457
|
protein folding
|
1.46
|
1.15e-05
|
GO:0031399
|
regulation of protein modification process
|
2.74
|
1.37e-05
|
GO:0048524
|
positive regulation of viral reproduction
|
1.25
|
1.56e-05
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.55
|
1.64e-05
|
GO:0055086
|
nucleobase, nucleoside and nucleotide metabolic process
|
1.59
|
2.00e-05
|
GO:0070271
|
protein complex biogenesis
|
1.95
|
2.19e-05
|
GO:0034470
|
ncRNA processing
|
2.75
|
2.21e-05
|
GO:0006368
|
transcription elongation from RNA polymerase II promoter
|
1.97
|
2.28e-05
|
GO:0006260
|
DNA replication
|
2.94
|
2.57e-05
|
GO:0050434
|
positive regulation of viral transcription
|
1.54
|
2.90e-05
|
GO:0050878
|
regulation of body fluid levels
|
1.61
|
2.95e-05
|
GO:0016044
|
cellular membrane organization
|
1.17
|
3.49e-05
|
GO:0051716
|
cellular response to stimulus
|
1.57
|
3.73e-05
|
GO:0007599
|
hemostasis
|
2.66
|
3.92e-05
|
GO:0033238
|
regulation of cellular amine metabolic process
|
2.58
|
4.00e-05
|
GO:2000243
|
positive regulation of reproductive process
|
1.60
|
4.09e-05
|
GO:0061024
|
membrane organization
|
1.57
|
4.41e-05
|
GO:0007596
|
blood coagulation
|
1.57
|
4.41e-05
|
GO:0050817
|
coagulation
|
1.58
|
4.46e-05
|
GO:0006461
|
protein complex assembly
|
1.24
|
4.67e-05
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
3.07
|
5.35e-05
|
GO:0006369
|
termination of RNA polymerase II transcription
|
2.51
|
6.25e-05
|
GO:0006353
|
transcription termination, DNA-dependent
|
1.22
|
7.09e-05
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
2.07
|
7.67e-05
|
GO:0015931
|
nucleobase, nucleoside, nucleotide and nucleic acid transport
|
1.22
|
8.40e-05
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.19
|
9.33e-05
|
GO:0051179
|
localization
|
1.94
|
1.06e-04
|
GO:0006913
|
nucleocytoplasmic transport
|
1.66
|
1.11e-04
|
GO:0018193
|
peptidyl-amino acid modification
|
1.53
|
1.34e-04
|
GO:0044092
|
negative regulation of molecular function
|
2.07
|
1.38e-04
|
GO:0048193
|
Golgi vesicle transport
|
1.22
|
1.40e-04
|
GO:0009889
|
regulation of biosynthetic process
|
1.59
|
1.55e-04
|
GO:0072521
|
purine-containing compound metabolic process
|
1.64
|
1.61e-04
|
GO:0016568
|
chromatin modification
|
2.72
|
1.61e-04
|
GO:0046782
|
regulation of viral transcription
|
1.92
|
1.78e-04
|
GO:0051169
|
nuclear transport
|
1.96
|
1.99e-04
|
GO:0006417
|
regulation of translation
|
2.20
|
2.33e-04
|
GO:0007059
|
chromosome segregation
|
1.53
|
2.62e-04
|
GO:0006753
|
nucleoside phosphate metabolic process
|
1.53
|
2.62e-04
|
GO:0009117
|
nucleotide metabolic process
|
1.66
|
3.11e-04
|
GO:0009259
|
ribonucleotide metabolic process
|
2.15
|
4.05e-04
|
GO:0051028
|
mRNA transport
|
1.45
|
5.26e-04
|
GO:0046483
|
heterocycle metabolic process
|
2.37
|
5.63e-04
|
GO:0006354
|
transcription elongation, DNA-dependent
|
2.14
|
6.38e-04
|
GO:2000241
|
regulation of reproductive process
|
1.47
|
6.75e-04
|
GO:0042060
|
wound healing
|
3.26
|
7.62e-04
|
GO:0006903
|
vesicle targeting
|
1.56
|
7.67e-04
|
GO:0043086
|
negative regulation of catalytic activity
|
1.39
|
7.97e-04
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
2.23
|
8.28e-04
|
GO:0006352
|
transcription initiation, DNA-dependent
|
1.26
|
8.44e-04
|
GO:0044281
|
small molecule metabolic process
|
1.79
|
8.79e-04
|
GO:0033365
|
protein localization to organelle
|
1.39
|
9.95e-04
|
GO:0006508
|
proteolysis
|
1.53
|
9.98e-04
|
GO:0006325
|
chromatin organization
|
1.80
|
1.23e-03
|
GO:0006605
|
protein targeting
|
1.38
|
1.24e-03
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.63
|
1.46e-03
|
GO:0009150
|
purine ribonucleotide metabolic process
|
2.26
|
1.64e-03
|
GO:0051168
|
nuclear export
|
2.42
|
1.68e-03
|
GO:0006405
|
RNA export from nucleus
|
2.45
|
1.78e-03
|
GO:0031124
|
mRNA 3'-end processing
|
2.22
|
2.10e-03
|
GO:0018196
|
peptidyl-asparagine modification
|
2.22
|
2.10e-03
|
GO:0018279
|
protein N-linked glycosylation via asparagine
|
1.19
|
2.16e-03
|
GO:0006810
|
transport
|
1.18
|
2.36e-03
|
GO:0051234
|
establishment of localization
|
2.42
|
2.72e-03
|
GO:0006367
|
transcription initiation from RNA polymerase II promoter
|
1.64
|
2.85e-03
|
GO:0009144
|
purine nucleoside triphosphate metabolic process
|
1.43
|
2.89e-03
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.42
|
2.96e-03
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.64
|
3.38e-03
|
GO:0009205
|
purine ribonucleoside triphosphate metabolic process
|
1.99
|
3.39e-03
|
GO:0045333
|
cellular respiration
|
4.36
|
3.40e-03
|
GO:0042255
|
ribosome assembly
|
1.21
|
3.58e-03
|
GO:0051252
|
regulation of RNA metabolic process
|
1.94
|
3.63e-03
|
GO:0010565
|
regulation of cellular ketone metabolic process
|
1.63
|
4.01e-03
|
GO:0009199
|
ribonucleoside triphosphate metabolic process
|
1.62
|
4.74e-03
|
GO:0009141
|
nucleoside triphosphate metabolic process
|
2.13
|
5.10e-03
|
GO:0006487
|
protein N-linked glycosylation
|
3.09
|
5.12e-03
|
GO:0000387
|
spliceosomal snRNP assembly
|
3.09
|
5.12e-03
|
GO:0009452
|
RNA capping
|
1.27
|
5.20e-03
|
GO:0065009
|
regulation of molecular function
|
1.73
|
5.51e-03
|
GO:0009203
|
ribonucleoside triphosphate catabolic process
|
1.73
|
5.51e-03
|
GO:0009207
|
purine ribonucleoside triphosphate catabolic process
|
1.29
|
6.29e-03
|
GO:0002376
|
immune system process
|
1.48
|
6.38e-03
|
GO:0007010
|
cytoskeleton organization
|
1.72
|
6.71e-03
|
GO:0009146
|
purine nucleoside triphosphate catabolic process
|
1.53
|
6.96e-03
|
GO:0006091
|
generation of precursor metabolites and energy
|
2.41
|
7.15e-03
|
GO:0070925
|
organelle assembly
|
2.17
|
7.49e-03
|
GO:0000236
|
mitotic prometaphase
|
1.70
|
8.32e-03
|
GO:0009261
|
ribonucleotide catabolic process
|
1.76
|
8.36e-03
|
GO:0006887
|
exocytosis
|
1.63
|
9.31e-03
|
GO:0015980
|
energy derivation by oxidation of organic compounds
|
1.55
|
9.59e-03
|
GO:0006917
|
induction of apoptosis
|
1.69
|
1.02e-02
|
GO:0051129
|
negative regulation of cellular component organization
|
3.87
|
1.04e-02
|
GO:0042274
|
ribosomal small subunit biogenesis
|
1.39
|
1.09e-02
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.52
|
1.11e-02
|
GO:0006163
|
purine nucleotide metabolic process
|
1.55
|
1.11e-02
|
GO:0012502
|
induction of programmed cell death
|
1.69
|
1.19e-02
|
GO:0009143
|
nucleoside triphosphate catabolic process
|
1.69
|
1.19e-02
|
GO:0009154
|
purine ribonucleotide catabolic process
|
2.79
|
1.27e-02
|
GO:0006612
|
protein targeting to membrane
|
1.87
|
1.27e-02
|
GO:0051052
|
regulation of DNA metabolic process
|
1.41
|
1.29e-02
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.32
|
1.49e-02
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
2.20
|
1.52e-02
|
GO:0031123
|
RNA 3'-end processing
|
3.02
|
1.60e-02
|
GO:0006370
|
mRNA capping
|
2.14
|
1.65e-02
|
GO:0051656
|
establishment of organelle localization
|
2.36
|
1.74e-02
|
GO:0051291
|
protein heterooligomerization
|
1.28
|
2.00e-02
|
GO:0050790
|
regulation of catalytic activity
|
2.05
|
2.03e-02
|
GO:0050851
|
antigen receptor-mediated signaling pathway
|
1.57
|
2.03e-02
|
GO:0048610
|
cellular process involved in reproduction
|
1.44
|
2.19e-02
|
GO:0009967
|
positive regulation of signal transduction
|
2.58
|
2.25e-02
|
GO:0000819
|
sister chromatid segregation
|
2.64
|
2.25e-02
|
GO:0006283
|
transcription-coupled nucleotide-excision repair
|
1.33
|
2.37e-02
|
GO:0051704
|
multi-organism process
|
1.40
|
2.48e-02
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.37
|
2.64e-02
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.18
|
2.71e-02
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.64
|
2.89e-02
|
GO:0070972
|
protein localization in endoplasmic reticulum
|
1.63
|
3.03e-02
|
GO:0006195
|
purine nucleotide catabolic process
|
1.35
|
3.14e-02
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
2.16
|
3.38e-02
|
GO:0000209
|
protein polyubiquitination
|
1.61
|
3.57e-02
|
GO:0009166
|
nucleotide catabolic process
|
2.58
|
3.67e-02
|
GO:0051650
|
establishment of vesicle localization
|
1.42
|
3.83e-02
|
GO:0010647
|
positive regulation of cell communication
|
3.09
|
4.06e-02
|
GO:0006900
|
membrane budding
|
1.54
|
4.11e-02
|
GO:0033043
|
regulation of organelle organization
|
1.61
|
4.25e-02
|
GO:0072523
|
purine-containing compound catabolic process
|
2.20
|
4.33e-02
|
GO:0006921
|
cellular component disassembly involved in apoptosis
|
5.15
|
4.51e-02
|
GO:0045136
|
development of secondary sexual characteristics
|
2.13
|
4.70e-02
|
GO:0002576
|
platelet degranulation
|
3.35
|
4.71e-02
|
GO:0048199
|
vesicle targeting, to, from or within Golgi
|